Allianz Asset Management GmbH Acquires 80,504 Shares of Encompass Health Co. (NYSE:EHC)

Allianz Asset Management GmbH lifted its holdings in Encompass Health Co. (NYSE:EHC) by 40.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 278,593 shares of the company’s stock after buying an additional 80,504 shares during the quarter. Allianz Asset Management GmbH owned about 0.28% of Encompass Health worth $25,728,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. TD Private Client Wealth LLC raised its stake in shares of Encompass Health by 2,870.0% in the third quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock worth $709,000 after acquiring an additional 7,089 shares during the last quarter. Los Angeles Capital Management LLC increased its holdings in shares of Encompass Health by 532.4% in the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after purchasing an additional 42,338 shares in the last quarter. Pathstone Holdings LLC raised its position in Encompass Health by 54.5% in the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after purchasing an additional 7,412 shares during the last quarter. Meeder Asset Management Inc. lifted its holdings in Encompass Health by 43.8% during the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock worth $6,417,000 after buying an additional 20,242 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in Encompass Health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after buying an additional 20,547 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on EHC. Barclays upped their price target on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. KeyCorp upped their target price on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. William Blair restated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Finally, Truist Financial reaffirmed a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Ten equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average price target of $107.67.

Encompass Health Trading Up 1.4 %

EHC opened at $98.86 on Tuesday. Encompass Health Co. has a twelve month low of $73.68 and a twelve month high of $104.55. The firm has a market cap of $9.96 billion, a PE ratio of 22.17, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The firm’s fifty day moving average is $96.01 and its two-hundred day moving average is $96.05.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 17th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Insider Buying and Selling at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 2.10% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.